期刊文献+

128例巨大甲状腺肿合并Graves甲亢^(131)Ⅰ治疗临床疗效分析 被引量:9

Analysis of 128 cases of Graves disease with large goiter treated with ^(131)Ⅰ
下载PDF
导出
摘要 目的探讨131Ⅰ碘治疗巨大甲状腺肿合并Graves甲亢的效果和影响因素。方法 128例Graves甲亢患者经SPECT估重、触诊、超声等方法综合判断甲状腺质量为(122.0±36.8)g(90~228 g),男性40例,女性88例,年龄(38.6±11.0)岁。按照如下公式计算131Ⅰ剂量:131Ⅰ剂量(MBq)=甲状腺质量(g)×每克甲状腺组织131Ⅰ剂量(MBq/g)/24 h摄131Ⅰ率(%)。给予131Ⅰ剂量为(662.3±432.9)MBq(222~3 700)。随访时间(15.9±9.9)个月(3~44.7个月)。6个月后治疗效果不佳者行第二次治疗。结果一次131Ⅰ治疗后3个月,68例(53.1%)甲状腺功能恢复正常,32例(25.0%)症状有所减轻,24例(18.8%)发生甲状腺功能减退症(甲减),4例(3.0%)甲亢症状加重。102例(79.6%)肿大的甲状腺恢复正常,24例(18.8%)甲状腺质量有所缩小,2例(1.35%)甲状腺质量增加。一次131Ⅰ治疗后6个月,84例(65.6%)甲状腺功能恢复正常,22例(17.2%)症状有所减轻,20例(17.2%)发生甲状腺功能减退症(甲减),2例(1.35%)甲亢症状加重。110例(85.9%)肿大的甲状腺恢复正常,16例(12.5%)甲状腺质量有所缩小,2例(1.35%)甲状腺质量增加。24例治疗失败患者,进行第二次放射性碘治疗后6个月后,14例(58.3%)甲状腺功能恢复正常,1例(4.1%)症状有所减轻,9例(37.5%)发生甲状腺功能减退症(甲减)。16例(66.7%)肿大的甲状腺恢复正常,8例(33.3%)甲状腺质量有所缩小。结论 131Ⅰ治疗可迅速缩小巨大甲状腺肿合并Graves甲亢患者甲状腺大小,并迅速缓解其症状,是替代外科手术的有效方法。重复治疗可有效治疗甲亢,但甲减发生率明显升高。个体化的131Ⅰ使用剂量可以优化治疗效果。 Objective To analysis the effects and factors of Graves disease with large goiter treated with 131Ⅰ.Methods 128 cases including 40 male and 88 female,(38.6 ±11.0)years old,with graves disease with Large Goiter(range 90~450g),the administered dose of 131Ⅰ was calculated using the following formula: The dose of 131Ⅰ(MBq) = thyroid weight(g)× dose of 131Ⅰ per g thyroid tissue(MBq/g)/ the absorption rate of 131Ⅰ in 24 hours.The dose of 131Ⅰ was given about 662.3±432.9(222~3 700)MBq.The second treatment was arranged when the treatment effects are not so good after 6 months,follow-up:15.9±9.9(3~44.7)months.Results 3 months after the first 131Ⅰ,thyroid function of 68 cases(53.1%) returned to normal,symptoms of 32(25.0%) cases relieved somewhat,24(18.8%) cases became hypothyroidism,4 cases(3.0%) became seriously.Thyroid weight of 102(79.6%)patients backed to normal,24(18.8%) patients reduced somewhat and 2(1.35%) patients increased.6 months after one dose of 131Ⅰ,thyroid function of 84 cases(65.6%) returned to normal,symptoms of 22 cases(17.2%) relived somewhat,20(17.2%) cases became hypothyroidism,hyperthyroidism symptoms of 2 cases(1.35%) became serious.Thyroid weight of 110 patients(85.9%) became normal,16 patients(12.5%) reduced somewhat and 2 patients(1.35%) increased.24 patients who failed in the first treatment received the second treatment after 6 months,thyroid function of 14 cases(58.3%) returned to normal,the symptoms of 1cases(4.1%) relieved somewhat,9 cases(37.5%)became hypothyroidism.Thyroid weight of 16 patients(66.7%) became normal,8 patients(33.3%) reduced somewhat.Conclusion Treatment with 131Ⅰ is an effective method for graves disease with Large Goiter,Repeated treatment can cure graves disease effectively,but often occur hypothyroidism.
出处 《安徽医学》 2011年第11期1860-1862,共3页 Anhui Medical Journal
关键词 巨大甲状腺肿 GRAVES甲亢 131碘治疗 Large goiter Graves disease Treatment with 131Ⅰ
  • 相关文献

参考文献7

二级参考文献16

  • 1康增寿,周前,刘世贞.Graves甲亢^(131)I治疗后早发甲低[J].中华核医学杂志,1995,15(1):26-28. 被引量:46
  • 2杨吉生 王强 胡明造 等.Graves病再次^131I治疗的剂量计算和病例选择[J].中华核医学杂志,2001,21:16-16.
  • 3刘学公 洪波 陈其霞 等.99TcmO4甲状腺SPECT显像433例分析[J].中国科学技术大学学报,1995,25(93):100-100.
  • 4Tamai H, Mukata T, Matsubayashi S,et al. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor ( rhG - CSF). J Clin Endocrinol Metab, 1993 ;77:1356--1360.
  • 5Heinrich B,Gross M,Goebel FD. Methimazole-induced agranulocytosis and granulocyte colony-stimulating factor. Ann Intern Med, 1989; 111:621 --622.
  • 6Toth EL, Mant MJ,Shivji S, et al. Propyithiouradl-induced agranulocytosis and unusual presentation and a possible mechanism. Am J Med, 1988; 85: 725 - 727.
  • 7Mezquita P, Luna V, Munoz TM, et al. Methimazole induced aplastic anemia in third exposure:successful treatment with recombinant human granulocyte colony-stimulating factor. Thyroid, 1998;8:791-794.
  • 8Tajiri J, Noguchi S, Mutakami N. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia . Thyroid, 1997; 7:575-578.
  • 9Miyasaka Y, Yoshimura M, Tabata S, et al. successful treatment of a patient with Graves disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris. Thyroid, 1997; 7: 621 - 624.
  • 10吴在德 主编.外科学:第5版[M].北京:人民卫生出版社,2001.649.

共引文献21

同被引文献57

  • 1刁丽娜,唐武儒,韦南仕.碘131治疗甲亢1956例疗效分析[J].医学信息(医学与计算机应用),2014,0(9):487-487. 被引量:1
  • 2黄昭穗,黄春红,刘开渊,黄胜立.TRAb检测在Graves甲亢诊断治疗中的价值[J].放射免疫学杂志,2005,18(2):88-89. 被引量:11
  • 3罗朝学,黄定德,刘开元,李前伟.^(131)I治疗303例Graves病早期变化分析[J].第三军医大学学报,2007,29(7):635-637. 被引量:5
  • 4中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南-甲状腺功能亢进症[J].中华内科杂志,2007,46:876-882.
  • 5Orsini F, Traino AC, Grosso M,et al, Personalization of ra- dioiodine treatment for Graves disease: a prospective, ran- domized study with a novel method for calculating the optimal ^131I - iodide activity based on target reduction of thyroid mass [ J]. Q J Nucl Med Mol Imaging,2012,56(6) :496 -502.
  • 6Matthiesen C, Thompson JS, Thompson D, et al. The effica- cy of radiation therapy in the treatment of Graves orbitopathy [ J ]. Int J Radiat Oncol Biol Phys,2012, 82 (1) : 117 -23.
  • 7Lind P. Strategies of radioiodine therapy for Graves'disease [ J ]. Eur J Nucl Med Mollmaging,2002,29 (2) :453 - 457.
  • 8Bartalena L, Marcocci C, Bogazzi F, et al. Relation between the rape for hyperthyroidism and the course of Graves" oph- thalmopathy[ J]. N Engl J Med,1998,338(2):73 -78.
  • 9Klein I, Ojamaa K. Thyroid hormone and the cardiovascular systerrn [ J ]. N Engl J Med, 2001,344 (4) :501 - 509.
  • 10Malik R, Hedgson H. The relationship between the thyroid shnd and the liver[J]. QJM,2002,95(5) :559 -569.

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部